28 February 2023 in Diabetes, Obesity and Metabolism
Dietary salt (NaCl) is essential to an organism's survival. However, today's diets are dominated by excessive salt intake, which significantly impacts individual and population health. High salt intake is closely linked to cardiovascular disease (CVD), especially hypertension, through a number of well‐studied mechanisms. Emerging evidence indicates that salt overconsumption may also be associated with metabolic disorders. In this review, we first summarize recent updates on the mechanisms of salt‐induced CVD, the effects of salt reduction and the use of salt substitution as a therapy. Next, we focus on how high salt intake can impact metabolism and energy balance, describing the mechanisms through which this occurs, including leptin resistance, the overproduction of fructose and ghrelin, insulin resistance and altered hormonal factors. A further influence on metabolism worth noting is the reported role of salt in inducing thermogenesis and increasing body temperature, leading to an increase in energy expenditure. While this result could be viewed as a positive metabolic effect because it promotes a negative energy balance to combat obesity, caution must be taken with this frame of thinking given the deleterious consequences of chronic high salt intake on cardiovascular health. Nevertheless, this review highlights the importance of salt as a noncaloric nutrient in regulating whole‐body energy homeostasis. Through this review, we hope to provide a scientific framework for future studies to systematically address the metabolic impacts of dietary salt and salt replacement treatments. In addition, we hope to form a foundation for future clinical trials to explore how these salt‐induced metabolic changes impact obesity development and progression, and to elucidate the regulatory mechanisms that drive these changes, with the aim of developing novel therapeutics for obesity and CVD.
21 October 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
16 November 2024 in Trends in Molecular Medicine
10 September 2025 in iScience
Dry eye, an ocular surface disorder, has become increasingly prevalent over the past few years due to air pollution and stress in daily life. Emerging studies on dry eye in both cellular and animal models indicate changes in ferroptosis-related markers. Furthermore, mitochondrial dysfunction, endoplasmic reticulum stress, and lysosomal abnormalities are involved in dry eye. Targeting ferroptosis and improving organelle function have made considerable progress in the treatment of dry eye. This review summarizes the evidence for ferroptosis and organelle damage in the ocular surface, elucidates their roles in dry eye pathogenesis, and discusses the interplay among ferroptosis, organelle dysfunction, and dry eye. Finally, it highlights targeted therapeutic strategies for mitigating dry eye symptoms.
2 January 2024 in Investigative Ophthalmology & Visual Science
Purpose: To elucidate the influence of dopamine receptor 1 (DRD1) on the proliferation of mouse corneal epithelial cells (MCECs) under inflammatory conditions. Methods: In vitro, immortalized MCECs (iMCECs) were treated with IL-1β, with and without pcDNA3.1_DRD1. Primary MCECs (pMCECs) were exposed to IL-1β, with and without DRD1 agonist (A68930). Cell proliferation was quantified using the Cell Counting Kit-8 (CCK-8) assay and immunofluorescence staining for Ki-67 and p63. Expression levels of NOD-like receptor protein 3 (NLRP3), IL-1β, and IL-6 were assessed. To establish a corneal injury model in mice, a 2-mm superficial keratectomy was performed. Either 0.1% A68930 or PBS was topically administered three times daily to the injured eyes for up to 5 days post-injury. Immunofluorescence analysis was employed to evaluate the expression of Ki-67, p63, and CD45 in mouse corneas. Western blotting and real-time quantitative PCR were utilized for quantitative analysis of DRD1, NLRP3, IL-1β, and IL-6 in mouse corneas. Corneal epithelial regeneration was monitored through fluorescein sodium staining for a duration of up to 5 days following the injury. Results: Overexpression of DRD1 and A68930 promoted MCEC proliferation and suppressed the expression of NLRP3, IL-1β, and IL-6 in vitro. Topical application of the 0.1% A68930 following mechanical corneal injury in mice led to increased Ki-67 and p63 expression compared to PBS treatment. Furthermore, topical administration of the 0.1% A68930 reduced the expression of CD45, NLRP3, IL-1β, and IL-6. Analysis with fluorescein sodium indicated accelerated corneal epithelial regeneration in the 0.1% A68930 treatment group. Conclusions: DRD1 treatment counteracts NLRP3-associated inflammation and facilitates epithelial repair of corneal injury.
1 June 2026 in Investigative Ophthalmology & Visual Science
This study aimed to evaluate the effects of chrysin on dry eye and to elucidate its underlying mechanisms. Public transcriptomic datasets were analyzed to identify ferroptosis-associated hub genes and to predict potential modulatory compounds. Ocular surface signs were evaluated using phenol red thread tests and corneal fluorescein staining. Chrysin was administered both in vivo and in vitro. Corneal ferroptosis and inflammatory levels were assessed by NOX2, 4-HNE, FACL4, GPX4, STING, and NLRP3 staining. HCE-T cells and primary mouse corneal epithelial cells were subjected to hyperosmotic conditions, whereas NOX2 and STING expression was modulated in HCE-T cells. Cell viability and mitochondrial morphology were evaluated using the CCK-8 assay and transmission electron microscopy. Intracellular levels of reactive oxygen species (ROS), Fe²⁺, and lipid peroxidation were measured using the fluorescent probes DCFH-DA, FeRhoNox-1, and BODIPY 581/591 C11, respectively. There was a significant upregulation of NOX2 and STING under dry eye conditions. In hyperosmolarity-stimulated corneal epithelial cells, chrysin enhanced cell viability. In benzalkonium chloride-induced dry eye mice, chrysin restored tear volume and alleviated corneal epithelial damage. Chrysin suppressed the expression of NOX2, 4-HNE, and FACL4 while promoting GPX4 expression in the corneal epithelium. NOX2 overexpression reversed chrysin-mediated inhibition of ROS accumulation, Fe2+ overload, and lipid peroxidation in vitro. Furthermore, chrysin attenuated STING-dependent activation of the NLRP3 inflammasome and reduced IL-1β and IL-6 expression, which were abolished by STING overexpression. Chrysin inhibits ferroptosis and inflammatory responses in corneal epithelial cells and improves ocular surface homeostasis in dry eye by suppressing the NOX2/ROS and STING/NLRP3 signaling pathways.